Yun et al. demonstrated that DAB2IP enhances miR-138 expression, which suppresses stem-like phenotypes in RCC by directly targeting ATP-binding cassette subfamily A member 13 (ABCA13) and EZH2. This evidence concerns the gene DAB2IP and renal cell carcinoma.